MDLN

Medline

Stock NASDAQ – Stock Market Prices, News & Analysis

Medline Inc is a company specializing in the manufacture and distribution of medical and surgical products for healthcare facilities.

$ 49.84
3.54 %

Medline

$ 49.84
3.54 %
MDLN

Medline Inc is a company specializing in the manufacture and distribution of medical and surgical products for healthcare facilities.

Price history of Medline
Price history of Medline

Performance & Momentum

6 Months 21.40 %
1 Year 21.40 %
3 Years 21.40 %
5 Years 19.51 %
Momentum
79

Strategic Analysis

Medline • 2026

Medline Inc positions itself as a key player in the manufacturing and distribution of medical devices and surgical products to American healthcare institutions, combining industrial expertise and a robust logistics network. Its ability to provide a wide range of integrated products meets a stable and growing demand in the healthcare sector.

Strengths
  • Recognized leadership in medical devices and hospital distribution in the United States
  • Diverse offering covering the surgical and medical needs of healthcare institutions
  • Integrated model combining manufacturing and distribution ensuring quality control and responsiveness
Weaknesses
  • Geographic exposure primarily concentrated in the American market
  • Sector subject to heavy regulation and specific constraints regarding health standards
Momentum

The positive and sustained momentum across multiple time horizons reflects a solid operational dynamic and a good adaptation to the needs of the healthcare market. This favorable trend suggests interesting stability for investors seeking a defensive profile with moderate growth potential.

Analysis performed 4 days ago

Similar stocks to Medline

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone